Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Sarcoma × Immunotherapy × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 3 Melanoma 2 Colorectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Recurrence 1 Radiation Injuries 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Bites and Stings 1

Interventions

Blood Specimen Collection 7 Radiosurgery 6 Ifosfamide 6 Doxorubicin 6 Surveys and Questionnaires 4 Radiotherapy 4 Proton Therapy 4 X-Rays 3 Surgical Procedures, Operative 3 Standard of Care 3 Radiation Dose Hypofractionation 3 Methods 3 Mesna 3 Magnetic Resonance Spectroscopy 3 pegfilgrastim 2 dexamethasone acetate 2 Vincristine 2 Trastuzumab 2 Restraint, Physical 2 Radiotherapy, Intensity-Modulated 2 Practice Guidelines as Topic 2 Palliative Care 2 Melphalan 2 Gene Expression Profiling 2 Exercise 2 Etoposide 2 Enhanced Recovery After Surgery 2 Educational Status 2 Early Intervention, Educational 2 Diet Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07396116 2026-02-12

FUSION-02

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Not yet recruiting

Radiation Injuries, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡